Michael Scolaro

Michael Scolaro

Dec 23, 2017

Group 6 Copy 611
3
Please wait...

About This Project

We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

Blast off!

Browse Other Projects on Experiment

Related Projects

Developing a New Mouse Model for Studying Chemotherapeutic Nephrotoxicity

A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute...

Making Inexpensive Insulin Using Microalgae

This page serves as an archive of our first proof-of-concept experiments to genetically modify microalgae before...

Identifying genes to stop sarcomas in kids and dogs

Sarcomas are life-threatening, often untreatable cancers that disproportionately affect dogs and children. We...

Backer Badge Funded